BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20557279)

  • 1. Acute porphyrias may be overlooked in patients taking methenamine hippurate.
    Webber PR; Aarsand AK; Sandvik AK; Skadberg Ø; Lindberg M; Sandberg S
    Clin Chem Lab Med; 2010 Sep; 48(9):1355-7. PubMed ID: 20557279
    [No Abstract]   [Full Text] [Related]  

  • 2. Remarks on the acute intermittent porphyria.
    Pfäfflin A
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):347-8; author reply 348. PubMed ID: 19564164
    [No Abstract]   [Full Text] [Related]  

  • 3. A family with acute intermittent porphyria.
    Billoo AG; Lone SW
    J Coll Physicians Surg Pak; 2008 May; 18(5):316-8. PubMed ID: 18541093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated porphyrins following propofol anaesthesia in acute intermittent porphyria.
    Elcock D; Norris A
    Anaesthesia; 1994 Nov; 49(11):957-8. PubMed ID: 7802240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perplexing acute or chronic somatic or psychiatric symptoms: possibly due to porphyria].
    Schattenberg AV; de Pauw BE
    Ned Tijdschr Geneeskd; 1998 Aug; 142(32):1801-4. PubMed ID: 9856148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic difficulties in acute intermittent porphyria with neurological manifestations: apropos of 2 cases].
    Paz-Sendín L; Ledesma-Rivero G; Chalgub-Moreno AM; Abrahan-Marcel EA; Berroa-Díaz F; Allen-Hilton W
    Rev Neurol; 2001 Jan 1-15; 32(1):96-7. PubMed ID: 11293111
    [No Abstract]   [Full Text] [Related]  

  • 7. A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen.
    Zhang J; Yasuda M; Desnick RJ; Balwani M; Bishop D; Yu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2389-96. PubMed ID: 21783436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of cimetidine treatment for acute relapse in intermittent porphyria.
    Horie Y; Norimoto M; Tajima F; Sasaki H; Nanba E; Kawasaki H
    Clin Chim Acta; 1995 Jan; 234(1-2):171-5. PubMed ID: 7758217
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT; Rees DC
    J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemin treatment in a case of porphyria variegata].
    Adam C; Hassoun A; Defresne C; Guilmot-Bruneau M; Wery-Follet B; Saussez-De Temmerman A
    Dermatologica; 1982; 165(6):640-6. PubMed ID: 7169140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute intermittent porphyria. Detection of asymptomatic carriers of the genetic defect].
    Grandchamp B; Grelier M; Nordmann Y
    Nouv Presse Med; 1975 Jun; 4(24):1801-2. PubMed ID: 1161481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness is the name of the game: clinical and biochemical evaluation of a case of a girl diagnosed with acute intermittent porphyria associated with autism.
    Luder AS; Mamet R; Farbstein I; Schoenfeld N
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):19-22. PubMed ID: 19267997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary excretion of porphyrins and their precursors. Longterm observations in acute intermittent porphyrias (author's transl)].
    Brugsch J; Müller H
    MMW Munch Med Wochenschr; 1979 Mar; 121(13):457-8. PubMed ID: 107424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Porphyria. What to think in the absence of a cause of abdominal pain].
    Bouizegarene P; Puy H; da Silva VP; Deybach JC
    Rev Prat; 2010 Dec; 60(10):1341-4. PubMed ID: 21425523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of hematin in acute porphyric relapse].
    Monsalve V; Wolff C; Gómez R; Armas Merino R; Canals C
    Rev Med Chil; 1979 Jan; 107(1):38-41. PubMed ID: 462025
    [No Abstract]   [Full Text] [Related]  

  • 16. Images in emergency medicine. Acute intermittent porphyria.
    Mumoli N; Vitale J; Cei M
    Ann Emerg Med; 2014 Feb; 63(2):267, 273. PubMed ID: 24438652
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
    Balwani M; Sardh E; Ventura P; Peiró PA; Rees DC; Stölzel U; Bissell DM; Bonkovsky HL; Windyga J; Anderson KE; Parker C; Silver SM; Keel SB; Wang JD; Stein PE; Harper P; Vassiliou D; Wang B; Phillips J; Ivanova A; Langendonk JG; Kauppinen R; Minder E; Horie Y; Penz C; Chen J; Liu S; Ko JJ; Sweetser MT; Garg P; Vaishnaw A; Kim JB; Simon AR; Gouya L;
    N Engl J Med; 2020 Jun; 382(24):2289-2301. PubMed ID: 32521132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.
    Gross U; Honcamp M; Daume E; Frank M; Düsterberg B; Doss MO
    Horm Metab Res; 1995 Aug; 27(8):379-83. PubMed ID: 7590628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dark red urine].
    Füessl HS
    MMW Fortschr Med; 2014 Apr; 156(7):33. PubMed ID: 24956650
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on patients with polychlorinated biphenyls poisoning. Determination of urinary coproporphyrin, uroporphyrin, delta-aminolevulinic acid, and porphobilinogen (author's transl)].
    Lu FJ; Chang KJ; Lin SC; Tung TC
    Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):990-5. PubMed ID: 6788895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.